Evidence map›Paper›PMID 34561429›Full record

Trial reportNature communications2021

Cardiac radiotherapy induces electrical conduction reprogramming in the absence of transmural fibrosis.

David M Zhang, Rachita Navara, Tiankai Yin, Jeffrey Szymanski, Uri Goldsztejn, Camryn Kenkel, Adam Lang, Cedric Mpoy, Catherine E Lipovsky, Yun Qiao and 9 more

2 registry-linked trialsAbstract readClinical Trial, Phase IClinical Trial, Phase II
In one paragraph

Trial report in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05439031 phase2recruitingnot on this mapstarted 2023, after this paper: background citation

StereoTactic Arrhythmia Radiotherapy in the NetherLands no. 2

TypeinterventionalSponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Ran2023 to 2027Enrolled12ConditionsVentricular Tachycardia, Arrythmia, CardiacArmsStereotactic Arrhythmia Radiotherapy
NCT06299176 phase1enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Phase 1 Feasibility and Safety of Whole Heart Radiotherapy for End-stage Heart Failure: First In-human Treatments

TypeinterventionalSponsorMcGill University Health Centre/Research Institute of the McGill University Health CentreRan2025 to 2026Enrolled6ConditionsHeart Failure NYHA Class III, Heart Failure NYHA Class IV, End-stage Heart Failure, Heart Failure With Reduced Ejection FractionArmsWhole Heart Radiation Therapy
3 · Its place in the literature

Who cites it

91 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Trial
  4. Article
  5. Development of a prospective clinical workflow for proton beam therapy of ventricular tachycardia.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  6. Review
  7. Extended follow-up of stereotactic body radiation therapy for refractory ventricular arrhythmias.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Stereotactic radioablation for ventricular tachycardia in patients untreatable by catheter ablation: evidence of efficacy, safety, and impact on coronary arteries.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

David M ZhangCenter for Noninvasive Cardiac Radioablation, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0002-4054-3312
Rachita NavaraCenter for Noninvasive Cardiac Radioablation, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0002-6183-4258
Tiankai YinDepartment of Medicine, Cardiovascular Division, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0003-0584-8791
Jeffrey SzymanskiDepartment of Radiation Oncology, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Uri GoldsztejnDepartment of Medicine, Cardiovascular Division, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0001-7040-7007
Camryn KenkelDepartment of Medicine, Cardiovascular Division, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Adam LangDepartment of Pathology, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Cedric MpoyDepartment of Radiation Oncology, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Catherine E LipovskyDepartment of Medicine, Cardiovascular Division, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Yun QiaoDepartment of Medicine, Cardiovascular Division, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Stephanie HicksDepartment of Medicine, Cardiovascular Division, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Gang LiDepartment of Medicine, Cardiovascular Division, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Kaitlin M S MooreCenter for Noninvasive Cardiac Radioablation, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Carmen BergomCenter for Noninvasive Cardiac Radioablation, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0002-0886-5055
Buck E RogersDepartment of Radiation Oncology, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Clifford G RobinsonCenter for Noninvasive Cardiac Radioablation, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Phillip S CuculichCenter for Noninvasive Cardiac Radioablation, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.
Julie K SchwarzCenter for Noninvasive Cardiac Radioablation, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA.ORCID http://orcid.org/0000-0003-2407-7531
Stacey L RentschlerCenter for Noninvasive Cardiac Radioablation, Washington University in St. Louis, School of Medicine, Saint Louis, MO, USA. Stacey.Rentschler@wustl.edu.ORCID http://orcid.org/0000-0002-1744-1238

Funding

NATIONAL RESEARCH SERVICE AWARD-MEDICAL SCIENTISTT32GM007200 · NIGMS · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 1985 to 2024
$59.8M
UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
A 3D IN VITRO DISEASE MODEL OF ATRIAL CONDUCTIONUH3HL141800 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CURIEL, DAVID TERRY, GEORGE, STEVEN CARL · 2019 to 2021
$4.0M
WNT SIGNALING IN CARDIAC CONDUCTION AND ARRHYTHMOGENESISR01HL130212 · NHLBI · WASHINGTON UNIVERSITY · PI RENTSCHLER, STACEY LYNN · 2016 to 2024
$4.0M
Genetic Modifiers of Radiation Therapy-Induced CardiotoxicityR01HL147884 · NHLBI · WASHINGTON UNIVERSITY · PI BERGOM, CARMEN · 2019 to 2023
$2.3M
Training in Integrative and Systems Biology of Cardiovascular DiseaseT32HL134635 · NHLBI · WASHINGTON UNIVERSITY · PI NERBONNE, JEANNE M. · 2017 to 2021
$1.8M
PURCHASE OF AN IMAGE-GUIDED SMALL-ANIMAL IRRADIATORS10OD020136 · OD · WASHINGTON UNIVERSITY · PI HALLAHAN, DENNIS E · 2015 to 2015
$600k
NHLBI NIH HHS R01 HL130212NHLBI NIH HHS R01 HL147884NHLBI NIH HHS T32 HL134635NHLBI NIH HHS UH3 HL141800NIGMS NIH HHS K12 GM068524NIGMS NIH HHS T32 GM007200NIH HHS S10 OD020136ODCDC CDC HHS S10 OD020136
6 · The paper itself

Abstract

Cardiac radiotherapy (RT) may be effective in treating heart failure (HF) patients with refractory ventricular tachycardia (VT). The previously proposed mechanism of radiation-induced fibrosis does not explain the rapidity and magnitude with which VT reduction occurs clinically. Here, we demonstrate in hearts from RT patients that radiation does not achieve transmural fibrosis within the timeframe of VT reduction. Electrophysiologic assessment of irradiated murine hearts reveals a persistent supraphysiologic electrical phenotype, mediated by increases in Na

Indexed as

Action PotentialsAnimalsConnexin 43Dose-Response Relationship, RadiationElectrocardiographyEndomyocardial FibrosisFemaleGene Expression RegulationHeartHeart Conduction SystemHeart RateHumansMaleMiceNAV1.5 Voltage-Gated Sodium ChannelSignal TransductionConnexin 43GJA1 protein, humanNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, human

Identifiers

PMID34561429
PMCPMC8463558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.